# FDA Inspection 981004 - Biomat USA, Incorporated - June 17, 2016

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-incorporated/71486ad2-49f3-4c5f-bcbe-5d76051787df
Source feed: FDA_Inspections

> FDA Inspection 981004 for Biomat USA, Incorporated on June 17, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 981004
- Company Name: Biomat USA, Incorporated
- Inspection Date: 2016-06-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1303232 - 2026-02-18](https://www.keypedia.com/records/fda_inspections/biomat-usa-incorporated/7fa8d789-dfde-4933-9618-63ff88ef8f19)
- [FDA Inspection 1049076 - 2018-04-12](https://www.keypedia.com/records/fda_inspections/biomat-usa-incorporated/8b07b549-ab95-4adb-a6bf-1db18ed36229)

Company: https://www.keypedia.com/companies/biomat-usa-incorporated/757527b1-1bb4-4399-8604-7d57669ceccb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d